Oslo University Hospital Rikshospitalet, Oslo (Norway)
0
follower
9
more
presentations
in this session
Cardiovascular risk assessment in multiple myeloma patients undergoing carfilzomib therapy: a new risk prediction model for cardiovascular adverse events